Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-262317
Filing Date
2017-08-18
Accepted
2017-08-18 16:57:57
Documents
1
Group Members
ADAM GRAYCHRISTOPHER SHACKELTONCOLISEUM CAPITAL PARTNERS II, L.P.COLISEUM CAPITAL PARTNERS, L.P.COLISEUM CAPITAL, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d446237dsc13da.htm SC 13D/A 112008
  Complete submission text file 0001193125-17-262317.txt   113702
Mailing Address 1600 BROADWAY SUITE 950 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 950 DENVER CO 80202 720 697 5200
BioScrip, Inc. (Subject) CIK: 0001014739 (see all company filings)

EIN.: 050489664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49459 | Film No.: 171041556
SIC: 8082 Services-Home Health Care Services

Mailing Address 105 ROWAYTON AVENUE ROWAYTON CT 06853
Business Address 105 ROWAYTON AVENUE ROWAYTON CT 06853 203-883-0100
Coliseum Capital Management, LLC (Filed by) CIK: 0001409751 (see all company filings)

EIN.: 223918079
Type: SC 13D/A